FORT WORTH, Texas--(BUSINESS WIRE)--Jun 24, 2025--
Operio Group is pleased to announce the appointment of Declan McLaughlin as its new Chief Executive Officer, effective immediately.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617486682/en/
McLaughlin brings leadership experience in operations, growth strategy, and team development. He is known for building structure, scaling teams, and leading with clarity. His approach aligns well with Operio’s long-term direction and goals.
This leadership transition was initiated by former CEO Alastair Sanderson, who now assumes the roles of Chief Business Development Officer and Chief Marketing Officer. The decision reflects Sanderson’s belief in hiring leaders with the experience and capabilities to take the business further.
“I’ve always believed in hiring people who are better than me,” said Sanderson. “Declan’s strengths complement ours and will allow me to focus on areas I’m most passionate about—business development and brand building.”
He added that McLaughlin’s experience is exactly what the company needs as it grows, calling his contributions critical to the group’s long-term success.
McLaughlin said, “I'm incredibly excited and honored to accept the CEO role at Operio Group. As a board member I've long admired what a unique business that Alastair and Richard Sanderson have built and Operio's commitment to growth and innovation. I'm eager to build on that strong foundation and add some tools and disciplines that I have learned in my career to make Operio a world class company. I look forward to working with our incredibly talented team to achieve even greater success together.”
From tablet press equipment and capsule filling machines to empty capsules, and ingredients, Operio is focused on providing reliable products and expert support to its customers. The leadership team believes that the new structure will accelerate innovation and help Operio respond faster to the needs of manufacturers and formulators around the world.
About Operio Group
Operio Group is a portfolio of companies serving the solid dose manufacturing industry, including CCS, Elizabeth, Index, LFA Machines, Scheu & Kniss, Stokes, and Vivion. Together, these brands provide tablet press equipment, capsule filling machines, spare parts, empty capsules, ingredients, and control systems to manufacturers in the food, beverage, nutraceutical, and pharmaceutical sectors. Founded in 2022, Operio Group was built to deliver complete solutions, not just products and services, through shared expertise and industry knowledge. Learn more at operiogroup.com.
Declan McLaughlin, Operio Group CEO.
LONDON (AP) — King Charles III has been “deeply touched” by the response to his update on his cancer treatment, Buckingham Palace said Saturday, adding that the monarch is pleased to have highlighted the value of screening programs for the disease.
Medics and health charities have praised the king for his openness, saying his statement on Friday had already prompted people to seek information about cancer.
In a strikingly personal video statement, the British monarch acknowledged that a cancer diagnosis can feel “overwhelming,” but said catching the disease early brings “the precious gift of hope.”
Here’s what to know about the king's condition and his message.
The 77-year-old king said in a statement broadcast Friday that his treatment schedule will be reduced in the new year, “thanks to early diagnosis, effective intervention and adherence to ‘doctors’ orders.’”
He encouraged others to take advantage of screening programs such as those for breast, bowel and cervical cancer offered by Britain’s public health service.
“Early diagnosis quite simply saves lives,” the king said in the statement aired during a “Stand Up to Cancer” telethon on TV station Channel 4. He said catching the disease early had allowed him “to continue leading a full and active life even while undergoing treatment.”
Charles has received outpatient treatment for almost two years. Buckingham Palace did not say the king is in remission, but that his treatment is moving to a “precautionary phase” and his condition will be monitored to ensure his continued recovery.
“I know from my own experience that a cancer diagnosis can feel overwhelming,” the king said in his video statement. “Yet I also know that early detection is the key that can transform treatment journeys, giving invaluable time to medical teams – and, to their patients, the precious gift of hope.”
Charles announced in February 2024 that he had been diagnosed with cancer, and, in a break from centuries of secrecy about royal health, he has since spoken about the illness, using his story to promote cancer awareness and treatment.
The openness has limits, though. The king has not disclosed what type of cancer he has or what kind of treatment he is receiving. The palace said it was an intentional decision designed to ensure his message reaches the widest possible audience.
The king’s cancer was discovered after treatment for an enlarged prostate. While doctors ruled out prostate cancer, tests revealed “a separate issue of concern,” palace officials said last year.
Charles suspended his public appearances for about two months after his diagnosis. Since returning to the public eye, he has visited cancer treatment centers across the country and shared stories with fellow patients.
Buckingham Palace said Charles “will be greatly encouraged and deeply touched by the very positive reaction" his message has generated. “He will be particularly pleased at the way it has helped to shine a light on the benefits of cancer screening programs,” it added.
British cancer charities said the number of people seeking information about cancer jumped after the king revealed he was undergoing treatment last year.
Cancer Research U.K. said about 100,000 people have visited its Screening Checker website since it was launched on Dec. 5, most of them since the king’s statement on Friday.
The charity's Chief Executive Michelle Mitchell said: “When public figures speak openly about their cancer diagnosis, it can prompt others to check in on their health.”
Broadcaster Jonathan Dimbleby, the king’s authorized biographer, said the statement was “a remarkable thing for a monarch to do.”
“It takes guts, and the fact that he came out and did that will save lives,’” Dimbleby said.
The Princess of Wales, who announced her own cancer diagnosis six weeks after her father-in-law, has also given updates on her treatment. Kate announced in January that her cancer is in remission.
Find more of AP’s coverage at https://apnews.com/hub/royalty
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
Britain's King Charles III attends an Advent Service at Westminster Abbey, in London, Wednesday, Dec. 10, 2025. (Chris Jackson/Pool Photo via AP)
